Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2003
10/16/2003WO2003059282A3 Human monoclonal antibodies against cd30
10/16/2003WO2003057152A3 Hair follicle growth
10/16/2003WO2003054216A3 Antibodies that immunospecifically bind to trail receptors
10/16/2003WO2003048321A3 Hybrid antibodies
10/16/2003WO2003046162A3 Process for the production of polypeptides in mammalian cell cultures
10/16/2003WO2003040316A3 Selective elimination of cd52+ cells and uses thereof
10/16/2003WO2003040311A3 Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4
10/16/2003WO2003035835A3 Glycoprotein compositions
10/16/2003WO2003033650A3 Recombinant renilla reniformis system for bioluminescence resonance energy transfer
10/16/2003WO2003029426A3 Human and murine cytokine polypeptides
10/16/2003WO2003029413A3 A novel g protein-coupled receptor, gave 10
10/16/2003WO2003027250A3 Monoclonal antibodies to the drug tilmicosin and a method for detecting the same
10/16/2003WO2003025133A3 Methods of making glycolmolecules with enhanced activities and uses thereof
10/16/2003WO2003016472A3 Hybrid interferon/interferon tau proteins, compositions and methods of use
10/16/2003WO2003014359A3 A fusion protein
10/16/2003WO2003012127A3 Assay for identifying inhibitors of hiv rt dimerization
10/16/2003WO2003012034A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/16/2003WO2003007685A3 Detecting and treating reproductive tract disorders
10/16/2003WO2003000930A3 Nucleotide sequences involved in plant disease resistance
10/16/2003WO2002098905A3 Enzymatic coupling of l-phenylalanine methyl ester and n-benzyloxycarbonyl-l-aspartic acid in a continuous or fed-batch process
10/16/2003WO2002098899A3 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
10/16/2003WO2002097043A3 Wnv core protein/capsid interacting protein and uses of the same
10/16/2003WO2002077211A3 A virus (cryptovirus) within the rubulavirus genus and uses therefor
10/16/2003WO2002070655A3 Mouse cytokine receptor
10/16/2003US20030195349 H. pylori flbA polypeptides, immunogenic and vaccinating compositions comprising H. pylori flbA polypeptides, and compositions for detection of an infection comprising H. pylori flbA polypeptides
10/16/2003US20030195347 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195346 An isolated amino acid sequences are expressed by a cell; for use as human secreted proteins such as human insulin, interferon, Factor VIII, human growth hormones
10/16/2003US20030195345 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195344 A DNA libraries having the vector sequences for coding the membrane receptor proteins, or fusion proteins, for binding the membrane-bound proteins; drug delivery target to specific cell site
10/16/2003US20030195338 Concatameric immunoadhesion
10/16/2003US20030195337 UL16 binding protein 4
10/16/2003US20030195336 Nucleic acid and polypeptide compositions encoding lepidopteran-toxic polypeptides
10/16/2003US20030195334 Cell culturing and expressing the protein, chimeric polypeptides, fusion proteins; membrane protein receptor is used to bind the protein drugs thrombolytic agents, interferons, interleukins, erythropoietins
10/16/2003US20030195333 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195148 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195146 Prepared by culturing Beauveria in medium; substances thus obtained are less toxic, specifically inhibit acyl-Coenzyme A: cholesterol acyltransferase, and inhibit formation of oil droplets in macrophages
10/16/2003US20030194800 For immunization, generation of packaging cell lines, and production of immunogenic compositions
10/16/2003US20030194798 For diagnositic, therapeutic, research, and drug discovery applications
10/16/2003US20030194794 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194793 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194792 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194791 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194790 DNA sequences coding for ester-group-cleaving enzymes
10/16/2003US20030194782 Methods for recombinant peptide production
10/16/2003US20030194779 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194778 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194777 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194776 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194775 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194774 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194773 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194772 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194771 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194770 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194769 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194768 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194767 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194766 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194765 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194761 Novel nucleic acid sequences encoding human fibroblast growth factor-like polypeptides
10/16/2003US20030194760 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194759 Synthesis and use of anti-reverse mRBA cap analogues
10/16/2003US20030194744 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194732 For treating neoplastic diseases by testing responsiveness to interferons
10/16/2003US20030194727 Screening nucleic acids that encode different artificial, chimeric proteins to identify a chimeric protein that alters a phenotypic trait of a cell or organism
10/16/2003US20030194720 Human ion channels
10/16/2003US20030194714 Production of achromosomal and anucleate cells useful for applications such as diagnositic and therapeutic uses, as well as research tools and agents for drug discovery
10/16/2003US20030194408 Antibody which specifically binds to at least two variants of an epitope of an HIV-1 Tat protein
10/16/2003US20030194406 P-cadherin as a target for anti-cancer therapy
10/16/2003US20030194404 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders
10/16/2003US20030194398 Having serine protease inhibitory activity
10/16/2003US20030194391 Vaccine
10/16/2003CA2481925A1 Therapeutic agent for patients having human fc.gamma.riiia
10/16/2003CA2481920A1 Antibody composition-containing medicament
10/16/2003CA2481837A1 Production process for antibody composition
10/16/2003CA2481658A1 Method of enhancing of binding activity of antibody composition to fcy receptor iiia
10/16/2003CA2481657A1 Cells of which genome is modified
10/16/2003CA2481656A1 Cells in which activity of the protein involved in transportation of gdp-fucose is reduced or lost
10/16/2003CA2481502A1 Hcv antiviral and cytotoxicity drug screening assay
10/16/2003CA2481090A1 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003CA2481039A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003CA2480786A1 Recombinant p. falciparum merozoite protein-142 vaccine
10/16/2003CA2480504A1 Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
10/16/2003CA2480450A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003CA2480052A1 Antibodies that specifically bind to gmad
10/16/2003CA2479927A1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/15/2003EP1352085A1 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states
10/15/2003EP1352075A2 Maize yellow stripe1 and related genes
10/15/2003EP1352063A2 Receptor nucleic acids and polypeptides
10/15/2003EP1352054A2 Aspergillus ochraceus 11 alpha hydrolase and oxidoreductase
10/15/2003EP1351985A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
10/15/2003EP1351977A1 Antimicrobial pseudopeptides
10/15/2003EP1351974A2 Using viruses to detect or purify proteins
10/15/2003EP1351968A1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
10/15/2003EP1351744A2 Erbb4 antagonists
10/15/2003EP1189627B1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies
10/15/2003EP0706568B1 Vertebrate apoptosis gene: compositions and methods
10/15/2003CN1449449A Methods of synthesizing cell-free protein
10/15/2003CN1449446A Streptococcus antigens
10/15/2003CN1449444A Design and construction of transcription template for synthesizing cell-free protein, and dilution batch-type method of synthesizing cell-free wheat germ protein
1 ... 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 ... 1125